ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1996-07-09

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.93.14.6929PMID 9556431PMCID PMC56166
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular and Clinical Advances in Anticancer Drug Resistance

  2012cited by this paper
• ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter.

  1996cited by this paper
• Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.

  1993cited by this paper
• Expression of the MDR1 gene in human cancers.

  1991cited by this paper

• Integrated transcriptomic and metabolomic analyses of pak choi [Brassica pekinensis (Lour.) Rupr] response to combined stress of acid rain and cadmium-containing atmospheric fine particulate matter

  2022cites this paper
• Genetics in breast cancer and treatment strategy : A current scenario

  2017cites this paper
• Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer.

  2016cites this paper
• Continuous de novo biosynthesis of haem and its rapid turnover to bilirubin are necessary for cytoprotection against cell damage

  2015cites this paper
• Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells.

  2013cites this paper
• Inhibition of the MRP1-mediated transport of the menadione-glutathione conjugate (thiodione) in HeLa cells as studied by SECM

  2012cites this paper
• acute lymphoblastic leukemia Expression of lung resistance protein and multidrug resistance-related protein ( MRP 1 ) in pediatric

  2010cites this paper
• Multidrug Resistance Mediated by MDR-ABC Transporters

  2009cites this paper
• The ability of selected pyridinium salts to increase the cytotoxic activity of vincristine but not doxorubicin towards sensitive and multidrug resistant promyelocytic leukaemia HL60 cells

  2008cites this paper
• University of Groningen Indomethacin induces apoptosis via a MRPI-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRPI

  2007cites this paper
• Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1

  2007cites this paper
• Role of multidrug resistance-associated protein 1 in airway epithelium

  2007cites this paper
• Correction and use of biomedical literature affected by scientific misconduct

  2007cites this paper
• Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase. Implications for increasing its ability to inhibit the growth of sensitive and multidrug resistant leukaemia HL60 cells.

  2007cites this paper
• Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines: comparisons with the National Cancer Institute data

  2006cites this paper
• Development and characterization of multidrug resistant human hepatocarcinoma cell line in nude mice.

  2006cites this paper
• Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia.

  2006cites this paper
• Multidrug resistance and minimal residual disease in childhood malignancies

  2005cites this paper
• Absorption of fumonisin B1 and aminopentol on an in vitro model of intestinal epithelium; the role of P-glycoprotein.

  2005cites this paper
• The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines

  2005cites this paper
• Modulation of Oral Drug Bioavailability: From Preclinical Mechanism to Therapeutic Application

  2005cites this paper
• The human multidrug-resistance-associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin.

  2004cites this paper
• Human intestinal absorption of imidacloprid with Caco-2 cells as enterocyte model.

  2004cites this paper
• Pharmacogenomics of MDR and MRP subfamilies.

  2004cites this paper
• Metabolism-mediated cytotoxicity of ochratoxin A.

  2004cites this paper
• The role of structural factors in the kinetics of cellular uptake of pyrazoloacridines and pyrazolopyrimidoacridines: implications for overcoming multidrug resistance towards leukaemia K562/DOX cells.

  2004cites this paper
• MRP2-Mediated Reduced Glutathione Transport in Protection Against Oxidant Stress

  2003cites this paper
• Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2).

  2003cites this paper
• P‐glycoprotein (ABCB1) but not multidrug resistance‐associated protein 1 (ABCC1) is induced by doxorubicin in primary cultures of rat astrocytes

  2003cites this paper
• Structure-activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition. identification of novel chemotherapeutic drug resistance modulators.

  2002cites this paper
• Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1

  2002cites this paper
• The Role of Drug Efflux Pumps in Acute Myeloid Leukemia

  2002cites this paper
• Resolution of P‐glycoprotein and non‐P‐glycoprotein effects on drug permeability using intestinal tissues from mdr1a (−/−) mice

  2002cites this paper
• Membrane Transporters as Drug Targets

  2002cites this paper
• The Mucosa of the Small Intestine

  2002cites this paper
• Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia.

  2001cites this paper
• The cloning and characterisation of a multidrug resistance associated protein (MRP) from wheat.

  2001cites this paper
• Functional expression of p‐glycoprotein and multidrug resistance‐associated protein (mrp1) in primary cultures of rat astrocytes

  2000cites this paper
• Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system.

  2000cites this paper
• Antibiotic efflux pumps.

  2000cites this paper
• Metabolic Engineering of Plant Cells in a Space Environment

  2000cites this paper
• Efflux of Dietary Flavonoid Quercetin 4′-β-Glucoside across Human Intestinal Caco-2 Cell Monolayers by Apical Multidrug Resistance-Associated Protein-2

  2000cites this paper
• Different expression of glutathione S‐transferase α, μ and π in childhood acute lymphoblastic and myeloid leukaemia

  1999cites this paper
• ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans.

  1999cites this paper
• Drug resistance in lung cancer.

  1999cites this paper
• Drug Resistance in Breast Cancer

  1999cites this paper
• Modeling the chemoprotective functions of glutathione S-transferases in cultured cell lines by heterologous expression.

  1999cites this paper
• Structural, mechanistic and clinical aspects of MRP1.

  1999cites this paper
• Multidrug resistance and retroviral transduction potential in human small cell lung cancer cell lines

  1999cites this paper
• Localization of a Substrate Specificity Domain in the Multidrug Resistance Protein*

  1999cites this paper
• Multidrug-resistance transporters.

  1999cites this paper
• Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2)

  1999cites this paper
• The influence of glutathione metabolism on multidrug resistance in MRP-overexpressing cells.

  1998cites this paper
• Mechanisms of resistance to xenobiotics in human therapy

  1998cites this paper
• In Vivo Characterization of the Drug Resistance Profile of the Major ABC Transporters and Other Components of the Yeast Pleiotropic Drug Resistance Network

  1998influential citation
• Characterization of the Regional Intestinal Kinetics of Drug Efflux in Rat and Human Intestine and in Caco-2 Cells

  1998cites this paper
• Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione.

  1998cites this paper
• The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs.

  1998cites this paper
• Mrp1 Multidrug Resistance‐Associated Protein and P‐Glycoprotein Expression in Rat Brain Microvessel Endothelial Cells

  1998cites this paper
• Role of glutathione S-transferases in the resistance of human colon cancer cell lines to doxorubicin.

  1998cites this paper
• ATP-dependent Transport of Reduced Glutathione on YCF1, the Yeast Orthologue of Mammalian Multidrug Resistance Associated Proteins*

  1998cites this paper
• Detection of a P-glycoprotein related pump in Chironomus larvae and its inhibition by verapamil and cyclosporin A.

  1998cites this paper
• Multidrug resistance protein and glutathione S-transferase P1-1 act in synergy to confer protection from 4-nitroquinoline 1-oxide toxicity.

  1998cites this paper
• Mechanisms of cellular anthracycline resistance in childhood acute leukemia

  1998cites this paper
• Clinical studies of reversal of drug resistance based on glutathione.

  1998cites this paper
• Expression of the multidrug resistance protein (MRP) in squamous cell carcinoma of the oesophagus and response to pre-operative chemotherapy.

  1998cites this paper
• Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P.

  1998cites this paper
• Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs).

  1998cites this paper
• Roles of MRP2 and oatp1 in Hepatocellular Export of Reduced Glutathione

  1998cites this paper
• Decreased drug accumulation without increased drug efflux in a novel MRP-overexpressing multidrug-resistant cell line.

  1998cites this paper
• Recent developments in drug resistance and apoptosis research.

  1998cites this paper
• Multidrug resistance in breast and bladder cancer cell lines

  1998cites this paper
• The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.

  1997cites this paper
• Modulation of liver canalicular transport processes by the tyrosine‐kinase inhibitor genistein: Implications of genistein metabolism in the rat

  1997cites this paper
• Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport.

  1997cites this paper
• Chemotherapy in cancer of the esophagus

  1997cites this paper
• ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene.

  1997cites this paper
• Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase.

  1997cites this paper
• Investigations on the role of efflux pumps in drug resistance of human cancer cells

  1997cites this paper
• Active efflux by multidrug transporters as one of the strategies to evade chemotherapy and novel practical implications of yeast pleiotropic drug resistance.

  1997cites this paper
• Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins.

  1997cites this paper
• Molecular aspects of hepatobiliary transport.

  1997cites this paper
• ATPase Activity of Purified Multidrug Resistance-associated Protein*

  1997cites this paper
• Complete inventory of the yeast ABC proteins

  1997cites this paper
• Hepatic glutathione and glutathione S-conjugate transport mechanisms.

  1997cites this paper
• d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.

  1996cites this paper